Adam Le
Adam Le is Senior Editor, EMEA, for PEI Group's private equity publications, overseeing the flow of global news and analysis for Private Equity International and Secondaries Investor. Based in London, Adam works closely with private equity-focused colleagues across PEI's offices in New York, London and Hong Kong. Prior to PEI, his roles included reporting on finance and technology for Bloomberg Japan.
Can you remember the most unexpected departures and appointments of the last 12 months?
Our most popular podcast episodes this year include a deep dive into the origins of zombie funds and CVs, and a 360-degree discussion on what it means to be a lead investor.
The $1.2bn secondaries transaction involves R1 RCM, a healthcare sector revenue cycle management services provider.
Fundraising, deal volume, new entrants and people news piqued readers’ attention in what was another dramatic year for the secondaries market.
The firm has temporarily delayed capital raising for GP Equity Solutions and is instead focusing on dealmaking, Secondaries Investor has learned.
The departure comes six months after the firm said it was opening in the UAE to deepen its push into the Gulf region.
Our latest episode of Second Thoughts involved a basket of onions, a permanent marker and two well-respected professionals from Kirkland & Ellis and CVC Secondary Partners.
In this podcast, CVC's Carlo Pirzio-Biroli and Kirkland's Ted Cardos literally peel back the onion on the year that was and look forward to what they believe will shape the secondaries market in 2025.
Swiss GP Gyrus Capital originally invested in Essential Pharma in 2019 as part of a family/founder succession plan process.
The Norgay Partners co-founder had advised firms including PJT Partners, Nomura, Northleaf Capital Partners, UBS and Morgan Stanley on executive search.